NCT03094312

Brief Summary

Epilepsy affects between 0.5 and 0.7% of the European population. Despite the availability of numerous drug treatments, one third of patients still have seizures, which are associated with significant cognitive and social complications and excess mortality. In these patients, surgical treatment to remove the epileptogenic zone (EZ), the region of the brain responsible for seizures, is the only approach that can allow control of the disease. However, before investigating this surgery, investigations have to answer two questions: (i) what is the location and extension of the EZ and (ii) what functional risks, both motor and cognitive, would represent the resection of this Cortical region? As it is a functional surgery, it is in fact inconceivable that the surgery will result in an over-handicap. For these reasons, all candidates for surgery benefit from a complete assessment including imaging examinations, a neuropsychological assessment and a long-term video-EEG recording to record seizures. Nevertheless, in some patients, this assessment does not give us a formal answer. In these subjects, it is then necessary to carry out a second step, consisting of an invasive exploration by implantation of intracerebral electrodes during a stereoencephalography (SEEG). Due to its temporal and spatial resolution, the SEEG allows, besides the precise determination of the EZ, to carry out a functional mapping of the cortical regions likely to be included in cortectomy. Conventionally, this mapping is carried out on the basis of the cortical electrical stimulations applied to the implanted electrodes. If this approach is very robust for exploring primary functions such as motor skills or language, it cannot be used to evaluate more complex cognitive tasks such as face recognition or attention Effective cognitive treatment on a daily basis. This has led to the development in recent years, in Lyon and Grenoble, of a complementary approach to cerebral stimulation: dynamic spectral imaging (ISD). Numerous experimental paradigms have demonstrated that the realization of a cognitive task associates with the generation within the cortical regions involved in its treatment of a particular cortical activity. This activity is characterized by oscillations of the cortical rhythm in high frequencies (\> 30 Hz), called gamma activities. The ISD thus consists in mapping this gamma activity during various cognitive tasks, thus making it possible to study more widely the complexity of the cognitive functions. Correlations between gamma activity and cognitive tasks have so far been exclusively performed in the non-epileptic cortex explored at the periphery of the EA during SEEG. Nevertheless, the cortical oscillatory pattern study associated with a specific cognitive task within the EZ could better anticipate complex cognitive deficits that could be generated by the resection of a cortical region. The main objective of this project is to establish the predictive character of the gamma cortical oscillatory pattern associated with a specific cognitive task on the risk of occurrence of a cognitive disorder after surgery of epilepsy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
45mo left

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Jun 2017Jan 2030

First Submitted

Initial submission to the registry

March 9, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 29, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

June 23, 2017

Completed
12.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2030

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

12.6 years

First QC Date

March 9, 2017

Last Update Submit

January 19, 2026

Conditions

Keywords

SEEGISDcognitive disorderepilepsy surgery

Outcome Measures

Primary Outcomes (1)

  • predictive character of the cortical gamma oscillatory pattern associated with a specific cognitive task on the risk of occurrence of a cognitive disorder after epilepsy surgery

    Relation between the presence in the epileptogenic zone of a gamma activation in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a postoperative neuropsychological deficit (Wilcoxon test)

    12 months post-surgery compare to preoperative assessment (SEEG)

Secondary Outcomes (5)

  • database on the dynamics of large cerebral networks underlying the main cognitive functions

    pre-surgical assessment (SEEG)

  • spatio-temporal organization of these networks with that predicted by fMRI

    preoperative assessment (SEEG, fMRI and cortical stimulations)

  • effect of intracerebral electrical stimulations

    preoperative assessment (SEEG, fMRI and cortical stimulations)

  • macro-electrophysiological recordings

    12 months post-surgery compare to preoperative assessment (SEEG)

  • micro-electrophysiological recordings

    12 months post-surgery compare to preoperative assessment (SEEG)

Study Arms (1)

Dynamic Spectral Imaging (ISD)

EXPERIMENTAL

Evaluation of cognitive functions by ISD

Procedure: Dynamic Spectral Imaging (ISD)

Interventions

cerebral stimulation: dynamic spectral imaging (ISD)

Dynamic Spectral Imaging (ISD)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient adult (18-65 y/o) without legal protection measures
  • Patient with a drug-resistant focal epilepsy
  • Patient with a SEEG exploration as part of pre-surgical assessment of epilepsy
  • patient with a consent form signed
  • Intellectual capacities compatible with cognitive tasks and the signing of informed consent
  • Affiliation to the social security

You may not qualify if:

  • Pregnant women: this is already a contraindication to the realization of a SEEG study
  • Subjects under 18 years of age or over 65 years of age
  • Patient not suffering from EFPR, or not scheduled for SEEG
  • Intellectual capacities incompatible with the cognitive tasks and / or the signature of a consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

RECRUITING

MeSH Terms

Conditions

EpilepsyCognitive Dysfunction

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Sylvain RHEIMS, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sylvain RHEIMS, MD

CONTACT

Anne-Laure CHARLOIS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2017

First Posted

March 29, 2017

Study Start

June 23, 2017

Primary Completion (Estimated)

January 23, 2030

Study Completion (Estimated)

January 23, 2030

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations